Malignant Mesothelioma, Advanced: Clinical Trials

1 trial for Malignant Mesothelioma, Advanced, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow Malignant Mesothelioma, Advanced: new trials by email Literature Review of Malignant Mesothelioma, Advanced trials Research Report on Malignant Mesothelioma, Advanced

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
CK-301 (cosibelimab) - Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
Phase 1Active not recruitingCheckpoint Therapeutics, Inc.2722017-09-202025-02-03

Narrower conditions

Carcinoma, Merkel Cell (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Small Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Endometrial Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Melanoma (1)  ·  Mesothelioma, Malignant (1)  ·  Neoplasms (1)  ·  Skin Neoplasms (1)

Broader conditions

Adenocarcinoma (1)  ·  Adenoma (1)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Carcinoma, Neuroendocrine (1)  ·  DNA Virus Infections (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)

Sponsors

Checkpoint Therapeutics, Inc. (1)

Countries

Australia (1)  ·  France (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Russia (1)  ·  South Africa (1)  ·  Spain (1)  ·  Thailand (1)  ·  Ukraine (1)

Results publications

PMID 37848259